Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care
Condition(s):Multiple MyelomaLast Updated:November 1, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:November 1, 2022Recruiting
Condition(s):Bone Turnover Rate Disorder; Calcium Metabolism DisordersLast Updated:January 25, 2022Completed
Condition(s):Type 2 Diabetes Mellitus; Bone RemodelingLast Updated:June 14, 2017Terminated
Condition(s):Erosive OsteoarthritisLast Updated:April 22, 2022Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:July 24, 2017Terminated
Condition(s):Bariatric Surgery CandidateLast Updated:March 7, 2024Not yet recruiting
Condition(s):Bone Turnover Status in Hypertensive PatientsLast Updated:December 4, 2015Completed
Condition(s):Type 1 DiabetesLast Updated:June 7, 2023Not yet recruiting
Condition(s):Osteoporosis; Postmenopausal Bone LossLast Updated:May 10, 2017Completed
Condition(s):Intestinal Failure; Osteoporosis; Insulin SensitivityLast Updated:October 23, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.